Abstract
Degradation of vascular extracellular matrix is important in atherosclerosis. Cysteine protease legumain is upregulated in atherosclerotic plaques. We recently reported that plasma legumain levels are high in patients with complex coronary lesions. This study investigated the association between legumain levels and cardiovascular events in 372 patients undergoing coronary angiography. Patients with acute coronary syndrome were excluded. Of the 372 patients, 225 had coronary artery disease (CAD). During a mean follow-up of 7.0 ± 4.3 years, cardiovascular events occured in 62 patients. Compared with 310 patients without events, 62 with events tended to have higher prevalence of complex lesions (15% vs. 10%). Notably, patients with events had higher legumain levels (median 5.51 vs. 4.90 ng/mL, P < 0.01) than those without events. A Kaplan-Meier analysis showed lower event-free survival in patients with legumain > 5.0 ng/mL than in those with ≤ 5.0 ng/mL (P < 0.01). In multivariate Cox regression analysis, legumain level was an independent predictor of cardiovascular events. The hazard ratio for legumain > 5.0 ng/mL for cardiovascular events was 2.18 (95%CI = 1.27–3.77, P < 0.01). Only among 225 patients with CAD, patients with events had higher legumain levels (5.49 vs. 4.73 ng/mL) than without events (P < 0.02). Legumain level was also a predictor of cardiovascular events in patients with CAD. Thus, high plasma legumain levels were associated with an increased risk of cardiovascular events in patients undergoing coronary angiography and those with stable CAD.
References
Lutgens SP, Cleutjens KB, Daemen MJ, Heeneman S (2007) Cathepsin cysteine proteases in cardiovascular disease. FASEB J 21:3029–3041
Liu J, Sukhova GK, Sun JS, Xu WH, Libby P, Shi GP (2004) Lysosomal cysteine proteases in atherosclerosis. Arterioscler Thromb Vasc Biol 24:1359–1366
Chen JM, Fortunato M, Stevens RA, Barrett AJ (2001) Activation of progelatinase A by mammalian legumain, a recently discovered cysteine proteinase. Biol Chem 382:777–783
Shirahama-Noda K, Yamamoto A, Sugihara K, Hashimoto N, Asano M, Nishimura M, Hara-Nishimura I (2003) Biosynthetic processing of cathepsins and lysosomal degradation are abolished in asparaginyl endopeptidase-deficient mice. J Biol Chem 278:33194–33199
Morita Y, Araki H, Sugimoto T, Takeuchi K, Yamane T, Maeda T, Yamamoto Y, Nishi K, Asano M, Shirahama-Noda K, Nishimura M, Uzu T, Hara-Nishimura I, Koya D, Kashiwagi A, Ohkubo I (2007) Legumain/asparaginyl endopeptidase controls extracellular matrix remodeling through the degradation of fibronectin in mouse renal proximal tubular cells. FEBS Lett 581:1417–1424
Papaspyridonos M, Smith A, Burnand KG, Taylor P, Padayachee S, Suckling KE, James CH, Greaves DR, Patel L (2006) Novel candidate genes in unstable areas of human atherosclerotic plaques. Arterioscler Thromb Vasc Biol 26:1837–1844
Mattock KL, Gough PJ, Humphries J, Burnand K, Patel L, Suckling KE, Cuello F, Watts C, Gautel M, Avkiran M, Smith A (2010) Legumain and cathepsin-L expression in human unstable carotid plaque. Atherosclerosis 208:83–89
Li W, Kornmark L, Jonasson L, Forssell C, Yuan XM (2009) Cathepsin L is significantly associated with apoptosis and plaque destabilization in human atherosclerosis. Atherosclerosis 202:92–102
Lunde NN, Holm S, Dahl TB, Elyouncha I, Sporsheim B, Gregersen I, Abbas A, Skjelland M, Espevik T, Solberg R, Johansen HT, Halvorsen B (2017) Increased levels of legumain in plasma and plaques from patients with carotid atherosclerosis. Atherosclerosis 257:216–223
Wu J, Wang W, Xie T, Chen Z, Zhou L, Song X, Kan H, Lv Y, Wu L, Li F, Yang D, Chen Y, Liu B, Zheng Y (2022) Identification of novel plasma biomarkers for abdominal aortic aneurysm by protein array analysis. Biomolecules 12:1853
Yang H, He Y, Zou P, Hu Y, Li X, Tang L, Zhu Z, Tai S, Tu T, Xiao Y, Chen M, Wu C, Zhou S (2020) Legumain is a predictor of all-cause mortality and potential therapeutic target in acute myocardial infarction. Cell Death Dis 11:1014
Lunde NN, Gregersen I, Ueland T, Shetelig C, Holm S, Kong XY, Michelsen AE, Otterdal K, Yndestad A, Broch K, Gullestad L, Nyman TA, Bendz B, Eritsland J, Hoffmann P, Skagen K, Gonçalves I, Nilsson J, Grenegård M, Poreba M, Drag M, Seljeflot I, Sporsheim B, Espevik T, Skjelland M, Johansen HT, Solberg R, Aukrust P, Björkbacka H, Andersen GØ, Halvorsen B (2020) Legumain is upregulated in acute cardiovascular events and associated with improved outcome: potentially related to anti-inflammatory effects on macrophages. Atherosclerosis 296:74–82
Umei TC, Kishimoto Y, Aoyama M, Saita E, Niki H, Ikegami Y, Ohmori R, Kondo K, Momiyama Y (2020) High plasma levels of legumain in patients with complex coronary lesions. J Atheroscler Thromb 27:711–717
Kishimoto Y, Saita E, Ohmori R, Kondo K, Momiyama Y (2024) High plasma concentrations of vanin-1 in patients with coronary artery disease. Heart Vessels 39:10–17
Ambrose JA, Israel DH (1991) Angiography in unstable angina. Am J Cardiol 68:78B–84B
Kishimoto K, Saita Y, Ohmori E, Kondo R, Momiyama Y (2024) High plasma levels of endosialin and cardiovascular events in patients undergoing coronary angiography. Heart Vessels 2024 Jan 8. https://doi.org/10.1007/s00380-023-02353-7
Anthony K, Akobeng (2007) Understanding diagnostic tests 3: receiver operating characteristic curves. Acta Paediatr 96:644–647
Arima H, Kubo M, Yonemoto K, Doi Y, Ninomiya T, Tanizaki Y, Hata J, Matsumura K, Iida M, Kiyohara Y (2008) High-sensitivity C-reactive protein and coronary heart disease in a general population of Japanese: the Hisayama Study. Arterioscler Thromb Vasc Biol 28:1385–1391
Momiyama Y, Kawaguchi A, Kajiwara I, Ohmori R, Okada K, Saito I, Konishi M, Nakamura M, Sato S, Kokubo Y, Mannami T, Adachi H, Kario K, Iso H, Ohsuzu F, Tsushima M (2009) Prognostic value of plasma high-sensitivity C-reactive protein levels in Japanese patients with stable coronary artery disease: the Japan NCVC-Collaborative inflammation cohort study. Atherosclerosis 207:272–276
Kidney Disease: Improving Global Outcomes (KDIGO) CKD Work Group (2013) KDIGO 2012 clinical practice guideline for the evaluation and management of chronic kidney disease. Kidney Int Suppl 3:1–150
Kunihiro Matsushita M, van der Velde BC, Astor M, Woodward AS, Levey PE, de Jong J, Coresh, Ron T, Gansevoort (2010) Association of estimated glomerular filtration rate and albuminuria with all-cause and cardiovascular mortality in general population cohorts: a collaborative meta-analysis. Lancet 375:2073–2081
Bozkurt B, Coats AJS, Tsutsui H, Abdelhamid CM, Adamopoulos S, Albert N, Anker SD, Atherton J, Böhm M, Butler J, Drazner MH, Michael Felker G, Filippatos G, Fiuzat M, Fonarow GC, Gomez-Mesa JE, Heidenreich P, Imamura T, Jankowska EA, Januzzi J, Khazanie P, Kinugawa K, Lam CSP, Matsue Y, Metra M, Ohtani T, Francesco Piepoli M, Ponikowski P, Rosano GMC, Sakata Y, Seferović P, Starling RC, Teerlink JR, Vardeny O, Yamamoto K, Yancy C, Zhang J, Zieroth S (2021) Universal definition and classification of heart failure: a report of the Heart Failure Society of America, Heart Failure Association of the European Society of Cardiology, Japanese Heart Failure Society and Writing Committee of the Universal Definition of Heart failure. Eur J Heart Fail 23:352–380
Gregersen I, Michelsen AE, Lunde NN, Åkerblom A, Lakic TG, Skjelland M, Ryeng Skagen K, Becker RC, Lindbäck J, Himmelmann A, Solberg R, Johansen HT, James SK, Siegbahn A, Storey RF, Kontny F, Aukrust P, Ueland T, Wallentin L, Halvorsen B (2020) Legumain in acute coronary syndromes: a substudy of the PLATO (platelet inhibition and patient outcomes) trial. J Am Heart Assoc 9:e016360
Ambrose JA (1991) Prognostic implications of lesion irregularity on coronary angiography. J Am Coll Cardiol 18:675–676
Meuwissen M, van der Wal AC, Koch KT, van der Loos CM, Chamuleau SA, Teeling P, de Winter RJ, Tijssen JG, Becker AE, Piek JJ (2003) Association between complex coronary artery stenosis and unstable angina and the extent of plaque inflammation. Am J Med 114:521–527
Ellis S, Alderman EL, Cain K, Wright A, Bourassa M, Fisher L (1989) Morphology of left anterior descending coronary territory lesions as a predictor of anterior myocardial infarction: a CASS Registry Study. J Am Coll Cardiol 13:1481–1491
Funding
This study was supported by a grant from the Honjo International Scholarship Foundation. Financial funding was also provided by Pfizer Japan Inc. However, these sponsors had no role in the design, analysis, or interpretation of our study.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
Our study has no conflicts of interest to disclose.
Additional information
Publisher’s Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Momiyama, Y., Kishimoto, Y., Saita, E. et al. Association between high plasma levels of legumain and cardiovascular events in patients undergoing coronary angiography. Heart Vessels (2024). https://doi.org/10.1007/s00380-024-02373-x
Received:
Accepted:
Published:
DOI: https://doi.org/10.1007/s00380-024-02373-x